On October 5, Globe Biotech, a Bangladeshi company announced that its first vaccine candidate had passed the pre-clinical trial on mice. And on October 17, Bancovid, along with two other vaccine candidates developed by the Globe Biotech Ltd, were included in the draft landscape of the World Health Organization (WHO). 

It is rather reassuring that the local company got the licence to produce the coronavirus vaccine for human trial on December 28. Given the global demand for vaccines against Covid-19, it is a rather reassuring that we are not lagging behind in our attempts to produce a vaccine against the disease.